Edwards Lifesciences Appoints New CFO, Announces Departure
Ticker: EW · Form: 8-K · Filed: Jul 10, 2024 · CIK: 1099800
| Field | Detail |
|---|---|
| Company | Edwards Lifesciences Corp (EW) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, cfo-appointment, personnel-change
TL;DR
Edwards Lifesciences has a new CFO starting July 15th, with the old one leaving July 12th.
AI Summary
Edwards Lifesciences Corporation announced on July 10, 2024, changes in its executive team. Specifically, the company appointed David E. Wood as Chief Financial Officer, effective July 15, 2024. Additionally, the company reported the departure of its former CFO, Robert H. Daily, Jr., effective July 12, 2024.
Why It Matters
A change in Chief Financial Officer can signal shifts in financial strategy or management priorities, impacting investor confidence and the company's financial outlook.
Risk Assessment
Risk Level: medium — Executive changes, especially at the CFO level, can introduce uncertainty regarding future financial strategies and operational direction.
Key Players & Entities
- Edwards Lifesciences Corporation (company) — Registrant
- David E. Wood (person) — Appointed Chief Financial Officer
- July 15, 2024 (date) — Effective date for new CFO
- Robert H. Daily, Jr. (person) — Departing Chief Financial Officer
- July 12, 2024 (date) — Effective date for departing CFO
- July 10, 2024 (date) — Date of report
FAQ
Who has been appointed as the new Chief Financial Officer of Edwards Lifesciences Corporation?
David E. Wood has been appointed as the new Chief Financial Officer of Edwards Lifesciences Corporation.
When is David E. Wood's appointment as CFO effective?
David E. Wood's appointment as CFO is effective July 15, 2024.
Who is the departing Chief Financial Officer?
Robert H. Daily, Jr. is the departing Chief Financial Officer.
When is Robert H. Daily, Jr.'s departure effective?
Robert H. Daily, Jr.'s departure is effective July 12, 2024.
What is the filing date of this 8-K report?
The filing date of this 8-K report is July 10, 2024.
Filing Stats: 761 words · 3 min read · ~3 pages · Grade level 10.2 · Accepted 2024-07-10 16:39:26
Key Financial Figures
- $1.00 — ich registered Common Stock, par value $1.00 per share EW New York Stock Exchange
Filing Documents
- ew-20240710.htm (8-K) — 27KB
- 0001099800-24-000061.txt ( ) — 148KB
- ew-20240710.xsd (EX-101.SCH) — 2KB
- ew-20240710_lab.xml (EX-101.LAB) — 21KB
- ew-20240710_pre.xml (EX-101.PRE) — 12KB
- ew-20240710_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EDWARDS LIFESCIENCES CORPORATION By: /s/ Linda J. Park Linda J. Park Date: July 10, 2024 Senior Vice President, Associate General Counsel and Corporate Secretary 3